scispace - formally typeset
Open AccessJournal ArticleDOI

Suicide and schizophrenia: a systematic review of rates and risk factors

Kahyee Hor, +1 more
- 01 Nov 2010 - 
- Vol. 24, Iss: 4, pp 81-90
Reads0
Chats0
TLDR
A systematic review of all original studies concerning suicide in schizophrenia published since 2004 found that number of prior suicide attempts, depressive symptoms, active hallucinations and delusions, and the presence of insight all had a strong evidential basis.
Abstract
Risk assessment is a core skill in psychiatry. Risk prediction for suicide in schizophrenia is known to be complex. We undertook a systematic review of all original studies concerning suicide in schizophrenia published since 2004. We found 51 data-containing studies (from 1281 studies screened) that met our inclusion criteria, and ranked these by standardized quality criteria. Estimates of rates of suicide and risk factors associated with later suicide were identified, and the risk factors were grouped according to type and strength of association with suicide. Consensus on the lifetime risk of suicide was a rate of approximately 5%. Risk factors with a strong association with later suicide included being young, male, and with a high level of education. Illness-related risk factors were important predictors, with number of prior suicide attempts, depressive symptoms, active hallucinations and delusions, and the presence of insight all having a strong evidential basis. A family history of suicide, and comorbid substance misuse were also positively associated with later suicide. The only consistent protective factor for suicide was delivery of and adherence to effective treatment. Prevention of suicide in schizophrenia will rely on identifying those individuals at risk, and treating comorbid depression and substance misuse, as well as providing best available treatment for psychotic symptoms.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Suicide and suicidal behaviour

TL;DR: Improved recognition and understanding of clinical, psychological, sociological, and biological factors might help the detection of high-risk individuals and assist in treatment selection.
Journal ArticleDOI

Premature Mortality Among Adults With Schizophrenia in the United States

TL;DR: In a US national cohort of adults with schizophrenia, excess deaths from cardiovascular and respiratory diseases implicate modifiable cardiovascular risk factors, including especially tobacco use, which highlight threats posed by substance abuse.
Journal ArticleDOI

Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis.

TL;DR: The effects of schizophrenia on years potential life lost and life expectancy seem to be substantial and not to have lessened over time, and development and implementation of interventions and initiatives to reduce this mortality gap are urgently needed.
Journal ArticleDOI

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

TL;DR: This guideline takes a holistic approach, addressing all aspects of the care of people with schizophrenia and related disorders, not only correct diagnosis and symptom relief but also optimal recovery of social function, and uses a clinical staging model as a framework for recommendations regarding assessment, treatment and ongoing care.
Journal ArticleDOI

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

TL;DR: An update and critical review of the pharmacology and clinical profiles of current antipsychotic drugs and drugs acting on novel targets with potential to be therapeutic agents in the future is provided.
References
More filters
Journal ArticleDOI

A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?

TL;DR: In light of the potential for second-generation antipsychotic medications to further adversely influence mortality rates in the decades to come, optimizing the general health of people with schizophrenia warrants urgent attention.
Journal ArticleDOI

The lifetime risk of suicide in schizophrenia: a reexamination.

TL;DR: This study estimates that 4.9% of schizophrenics will commit suicide during their lifetimes, usually near illness onset.
Journal ArticleDOI

Schizophrenia and suicide: systematic review of risk factors

TL;DR: Prevention of suicide in schizophrenia is likely to result from treatment of affective symptoms, improving adherence to treatment, and maintaining special vigilance in patients with risk factors, especially after losses, according to the international literature on case-control and cohort studies.
Journal ArticleDOI

Conditions predisposing to suicide: a review

TL;DR: By reviewing causes of death among cohorts of various major disease entities or conditions, one may infer that a large majority of suicides are associated with a relatively small number of conditions.
Related Papers (5)